Related Experiment Video
Updated: Feb 9, 2026

Assessment of Sexual Behavior of Male Mice
Published on: March 5, 2020
Flibanserin for hypoactive sexual desire disorder in premenopausal women
Jennifer N Clements1, Brittany Thompson
1Jennifer N. Clements is an associate professor in the Department of Pharmacy Practice at Presbyterian College School of Pharmacy in Clinton, S.C. At the time this article was written, Brittany Thompson was a doctor of pharmacy student at Presbyterian College School of Pharmacy. She is now an ambulatory care resident at the University of North Carolina. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
Flibanserin is a mixed 5-HT1A agonist and 5-HT2A antagonist for treatment of premenopausal women with hypoactive sexual desire disorder. It is the first FDA-approved treatment for this disorder and can improve the number of satisfying sexual events. The drug has been associated with hypotension and syncope.
Related Concept Videos
Desirable Characteristics in Others
Sexually Transmitted Infections
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Intrinsically Disordered Proteins
Development of the Sexual Organs in the Embryo and Fetus
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

